Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 140.28-4.4613.37610.65-249.43

What is the latest EBIT Growth ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Growth ratio of SOTAC PHARMACEUTICALS is 140.28 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025140.28
Mar2024-4.46
Mar202313.37
Mar2022610.65
Mar2021-249.43

How is EBIT Growth of SOTAC PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 140.28
Positive
Mar2024 -4.46
Negative
Mar2023 13.37
-97.81
Mar2022 610.65
Positive
Mar2021 -249.43 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹129.9 Cr 15.6% 3.6% -11.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

15.6%

3.6%

-11.1%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses